Correlation Between Centessa Pharmaceuticals and Kandi Technologies

Can any of the company-specific risk be diversified away by investing in both Centessa Pharmaceuticals and Kandi Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Centessa Pharmaceuticals and Kandi Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Centessa Pharmaceuticals PLC and Kandi Technologies Group, you can compare the effects of market volatilities on Centessa Pharmaceuticals and Kandi Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Centessa Pharmaceuticals with a short position of Kandi Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Centessa Pharmaceuticals and Kandi Technologies.

Diversification Opportunities for Centessa Pharmaceuticals and Kandi Technologies

-0.51

Correlation Coefficient

Centessa Pharmaceuticals  Kandi Technologies

Excellent diversification

The 3 months correlation between Centessa and Kandi is -0.51. Overlapping area represents the amount of risk that can be diversified away by holding Centessa Pharmaceuticals PLC and Kandi Technologies Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kandi Technologies and Centessa Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Centessa Pharmaceuticals PLC are associated (or correlated) with Kandi Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kandi Technologies has no effect on the direction of Centessa Pharmaceuticals i.e., Centessa Pharmaceuticals and Kandi Technologies go up and down completely randomly.

Pair Corralation between Centessa Pharmaceuticals and Kandi Technologies

Given the investment horizon of 90 days Centessa Pharmaceuticals PLC is expected to generate 0.69 times more return on investment than Kandi Technologies. However, Centessa Pharmaceuticals PLC is 1.46 times less risky than Kandi Technologies. It trades about 0.02 of its potential returns per unit of risk. Kandi Technologies Group is currently generating about -0.15 per unit of risk. If you would invest  1,646  in Centessa Pharmaceuticals PLC on September 15, 2024 and sell it today you would earn a total of  11.00  from holding Centessa Pharmaceuticals PLC or generate 0.67% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Centessa Pharmaceuticals PLC  vs.  Kandi Technologies Group

Centessa Pharmaceuticals

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Centessa Pharmaceuticals PLC are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, Centessa Pharmaceuticals is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Kandi Technologies

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Kandi Technologies Group has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's fundamental indicators remain fairly strong which may send shares a bit higher in January 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Pair Trading with Centessa Pharmaceuticals and Kandi Technologies

The main advantage of trading using opposite Centessa Pharmaceuticals and Kandi Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Centessa Pharmaceuticals position performs unexpectedly, Kandi Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kandi Technologies will offset losses from the drop in Kandi Technologies' long position.

The idea behind Centessa Pharmaceuticals PLC and Kandi Technologies Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.